QuarterMate Concentrate

Manufacturer
WestAgro, Inc. | K Klean dba WestAgro, Inc.
Effective date
2021-12-13
Label type
OTC ANIMAL DRUG LABEL
Version
9
Source
full-release
Hydrated at
2026-06-01 02:41:12

Label at a glance#

ProductQuarterMate Concentrate
Active ingredientIODINE
Label structure16 sections

Storage and handling

STORAGE AND DISPOSAL THOROUGHLY RINSE ALL MEASURING DEVICES AND STORE OUT OF REACH OF CHILDREN.   Avoid contact with food or feed.  Avoid storing near heat or open flame.  Keep from freezing.  If product is frozen, thaw in a warm room and mix well before using.  Keep container tightly closed when not in use.  Do not reuse empty container. Rinse empty container before disposing in a safe manner.

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

DIRECTIONS FOR USE:

GENERAL INSTRUCTIONS

  • Dilute before using.  See "Directions for Dilution".
  • Consult your veterinarian before using teat dip on a cow with sore or chapped teats.
  • Thoroughly clean and sanitize teat dip cup before each milking.  Use fresh teat dip for each milking.  Dip solution should be changed if it becomes visibly dirty or if sediment is introduced.  Do not pour used teat dip back into original container.
  • Do not use Quarter Mate Concentrate for cleaning or sanitizing equipment.

DIRECTIONS FOR DILUTION

Automatic blending

  • Dilute Quarter Mate Concentrate through a West Agro blending system.  Follow operating instructions.  When diluted, Quarter Mate Concentrate will yield a ready-to-use 0.1% iodine teat dip with glycerin.
  • NOTE:  When diluting automatically, use only the West Agro blending delivery system.  Use of any other product may cause injury or damage to animals or equipment.  Finished product could result which may not be effective as a teat dip.

Manual Blending

  • Quarter Mate Concentrate must be diluted before use.  Failure to follow the following instructions may result in a product which may not be effective as a teat dip or which may cause injury to animal.
  • Thoroughly clean a five gallon blending container available through your West Agro dealer.
  • Add three (3) gallons of potable water in the blending container followed by one (1) gallon of Quarter Mate Concentrate.
  • Mix thoroughly by shaking closed blending container.
  • When properly diluted, one gallon of Quarter Mate Concentrate will yield four (4) gallons of a ready-to-use 0.1% iodine teat dip with glycerin.

PRE-DIPPING

  • Make sure udder and teats are clean and dry.
  • Check milk and udder for mastitis.
  • Dip or spray cow's teats with properly diluted Quarter Mate Concentrate.
  • Allow 15 to 30 seconds contact time.
  • Dry cow's teats with a single service paper towel before milking.
  • Attach milker unit.

POST-DIPPING

  • Immediately after removing inflations, dip or spray cow's teats with properly diluted Quarter Mate Dip Concentrate.  Do not wipe.
  • If outside temperature is below freezing, allow teat dip to air-dry on cow's teats before cow leaves the parlor; or allow teat dip to remain on cow's teats before cow leaves the parlor then dry teats with a single service paper towel.  Failure to follow these directions may result in frozen teats and injured animals.

Color added to indicate contact with the animal.

SPL UNCLASSIFIED SECTION

Made in U.S.A.

0116-E0405

Copyright 2005, West Agro, Inc.

SPL UNCLASSIFIED SECTION

WestAgro

QuarterMate Concentrate

With Glycerin

SPL UNCLASSIFIED SECTION

Sellador De Pezones Desinfectante Con Glicerina

Este producto esta concentrado, por lo tanto diluya antes de usar.

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENT:
Iodine ......................................... 0.42% w/v
After dilution according to directions
Iodine ......................................... 0.1%

From polyethoxy polypropoxy polyethoxy ethanol-iodine complex
pH 5 minumum

SPL UNCLASSIFIED SECTION

I-tech
PATENTED FREE IODINE TECHNOLOGY
U.S. Patent No 4,271,149

NPE FREE Formula

ACT
ADVANCED CONDITIONING TECHNOLOGY

U.S. Patent No.
5,368,868

Manufactured by:
WESTAGRO
11100 N. Congress Ave. Kansas City, MO
63153-1296

SPL UNCLASSIFIED SECTION

0116

NDC 33392-116

SPL UNCLASSIFIED SECTION

  • Pre-dip, post-dip, the only dip you need.
  • Elevated free iodine for fast kill of mastitis causing organisms.
  • Unique pH balance formula has glycerin plus cosmetic grade complexors for excellent skin conditioning.
  • University tested using National Mastitis Council protocols.  Proven effective in reducing the incidence of mastitis.
  • Contains food grade ingredients to eliminate residue concerns.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

! CAUTION

MANTENER FUERA DEL ALCANCE DE LOST NINOS

! CUIDADO

SPL UNCLASSIFIED SECTION

SI USTED NO PURDE LEER ESTA ETIQUETA, POR FAVOR PIDA A ALGUIEN MAS QUE SE LA LEA ANTES DE USAR ESTE PRODUCTO

SPL UNCLASSIFIED SECTION

FIRST AID
Contact with product can cause irritation to eyes.
Avoid contact with eyes.
Eye Contact:  Flush with water.
If Swallowed:  Drink large quantities of water and induce vomiting.

STORAGE AND HANDLING SECTION

STORAGE AND DISPOSAL

THOROUGHLY RINSE ALL MEASURING DEVICES AND STORE OUT OF REACH OF CHILDREN.  Avoid contact with food or feed.  Avoid storing near heat or open flame.  Keep from freezing.  If product is frozen, thaw in a warm room and mix well before using.  Keep container tightly closed when not in use.  Do not reuse empty container.

Rinse empty container before disposing in a safe manner.

SPL UNCLASSIFIED SECTION

Read and understand all directions before using this product.  For additional information refer to the Material Safety Data Sheet (MSDS) available from your West Agro dealer.

SPL UNCLASSIFIED SECTION

CHEMTREC EMERGENCY No. 1-800-424-9300

SPL UNCLASSIFIED SECTION

NET
CONTENTS:

LOT NO:

EXPIRATION DATE:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1423947iodine 0.42 % Topical SolutionPSN9
1423952QuarterMate Concentrate With Glycerin 0.42 % Topical SolutionPSN9
1423952iodine 4.2 MG/ML Topical Solution [QuarterMate Concentrate]SBD9
1423947iodine 4.2 MG/ML Topical SolutionSCD9
1423947iodine 0.42 % Topical SolutionSY9
1423952QuarterMate Concentrate 0.42 % Topical SolutionSY9
1423952QuarterMate Concentrate 4.2 MG/ML Topical SolutionSY9

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
5f30b278-5791-4113-8781-878a9221ef8aProduct name220230125
2a70c781-a755-4d76-b20a-a958acfbdcdcProduct name220190619
304592ef-4a8a-4c22-8e8c-af73aa3d60e5Product name120180703
ac0821a1-ce75-4ea7-880a-59eecaecdf22Product name120180703
db5dc4f9-b907-46f6-8fb7-babcf04bbe5cProduct name120180619
41e9d6cf-3ed7-4c44-a57e-0685058d0896Product name120170824
5e652c92-68fd-426b-b0e7-5fc64e0b9f99Product name120170309
ddc0c11a-bba8-408f-b3c7-c4828b4bcc8cProduct name120150421

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
33392-116-23QuarterMate Concentrate7571 L in 1 TANKSOLUTION, CONCENTRATE75719
33392-116-27QuarterMate Concentrate1042.2 L in 1 TANKSOLUTION, CONCENTRATE1042.29

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
33392-116QUARTERMATE CONCENTRATE (IODINE) SOLUTION, CONCENTRATE [WESTAGRO, INC.]92 package rows20211214_5b0510eb-d9b6-42ee-a2d0-66a16e346fa3.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
IODINEACTIVE INGREDIENT9679TC07X44
IODINEACTIVE MOIETY9679TC07X44
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSL4
DOCUSATE SODIUMINACTIVE INGREDIENTF05Q2T2JA04
GLYCERININACTIVE INGREDIENTPDC6A3C0OX4
POLOXAMER 335INACTIVE INGREDIENTG6DQL26D504
POLOXAMER 403INACTIVE INGREDIENT2E9U4Y94DB4
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I4
SODIUM IODIDEINACTIVE INGREDIENTF5WR8N145C4
WATERINACTIVE INGREDIENT059QF0KO0R4
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEE4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
33392-11633392-116-27, 33392-116-23

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 353 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ICREAM / TOPICAL69 mgExact identifier — unii candidate
174 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLINJECTION, SOLUTION / INTRAMUSCULAR25 mgExact identifier — unii candidate
61 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOAP / TOPICAL0.76 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / OPHTHALMIC12 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / INTRAMUSCULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEEGRANULE, FOR SUSPENSION / ORAL450 mgExact identifier — unii candidate
29 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCLOTH / TOPICAL0.05 mg/mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / VAGINAL227.9 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / PARENTERALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / SOFT TISSUEADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / SUBCUTANEOUS31.45 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXPASTE, DENTIFRICE / DENTAL18 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRAMUSCULAR176 mgExact identifier — unii candidate
174 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION/ DROPS / AURICULAR (OTIC)1 mgExact identifier — unii candidate
61 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSUSPENSION/ DROPS / ORAL15 mgExact identifier — unii candidate
61 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEEENEMA / RECTAL150 mgExact identifier — unii candidate
29 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR5.4 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INFILTRATIONADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLFILM, SOLUBLE / ORAL7 mgExact identifier — unii candidate
61 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ICREAM / VAGINAL0.19 %w/wExact identifier — unii candidate
174 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSPRAY, METERED / NASAL1.2 mg/1mlExact identifier — unii candidate
61 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION / ENDOTRACHEALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXPASTE / DENTAL20 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IEMULSION / ORALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLTABLET, CHEWABLE / ORAL4 mgExact identifier — unii candidate
61 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEEGEL / TOPICAL58 mgExact identifier — unii candidate
29 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLTABLET, CHEWABLE, EXTENDED RELEASE / ORAL12 mgExact identifier — unii candidate
61 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / PERIDURALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS136.55 mgExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXGEL / TOPICAL500 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM IODIDESODIUM IODIDEF5WR8N145CSPONGE / TOPICAL0.74 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR27 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRADISCALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEEPOWDER, FOR SOLUTION / ORAL10 mg/5mlExact identifier — unii candidate
29 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLLOTION / TOPICAL211 mgExact identifier — unii candidate
61 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEECREAM / TOPICAL46 mgExact identifier — unii candidate
29 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEETROCHE / ORAL948 mgExact identifier — unii candidate
29 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / DENTAL15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRAMUSCULAR78 mgExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, EMULSION / INTRAVENOUS24100 mgExact identifier — unii candidate
75 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLCAPSULE / ORAL131 mgExact identifier — unii candidate
61 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISUSPENSION, EXTENDED RELEASE / INTRADERMALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IFILM, EXTENDED RELEASE / TRANSDERMAL0.85 mgExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION, CONCENTRATE / ORAL200 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLTABLET / ORAL197 mgExact identifier — unii candidate
61 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSPRAY / NASAL22.3 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ITABLET / ORAL10 mgExact identifier — unii candidate
174 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLLIQUID / INTRAVENOUS18 mgExact identifier — unii candidate
61 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSUSPENSION / RECTAL904 mgExact identifier — unii candidate
61 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, FILM COATED / ORAL1.55 mgExact identifier — unii candidate
75 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEESUSPENSION / OPHTHALMIC2 mgExact identifier — unii candidate
29 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLCAPSULE, LIQUID FILLED / ORAL360 mgExact identifier — unii candidate
61 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRABURSALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / AURICULAR (OTIC)25 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / INTRASYNOVIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRATUMORADJ PHExact identifier — unii candidate
174 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 11 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
IodineIODINENice-Pak Products, LLC857f13fe-51c9-4e5b-b5e2-a981dedabf712026-03-12Warnings, Adverse reactionsName fallback
generic name: IODINE
IodineIODINEUnited Natural Foods, Inc. dba UNFI8e840855-d210-4a99-b73f-6c69dcf2b6fb2026-02-16WarningsName fallback
generic name: IODINE
IODDO IODINEIODINEEVI LABS4af8552c-1f2b-84ad-e063-6394a90abb622026-02-16WarningsName fallback
generic name: IODINE
IodineIODINEWalgreen Co.d3d44c9f-4eb6-4e5b-9943-c0f80f06952d2026-02-12Warnings, Adverse reactionsName fallback
generic name: IODINE
IodiumIODINEBoiron85cd5e7a-52b6-0bb7-e053-2a91aa0aaa142023-11-13Name fallback
generic name: IODINE
IodiumIODINEBoiron85cd0c27-7859-5fd8-e053-2a91aa0a7c692023-11-13Name fallback
generic name: IODINE
IodiumIODINEBoiron85cd0c27-782d-5fd8-e053-2a91aa0a7c692023-11-13Name fallback
generic name: IODINE
IodiumIODINEBoiron724cb010-7c5d-11e6-8589-424c583030312023-11-13Name fallback
generic name: IODINE
IodiumIODINEBoiron85cd3f96-b800-f192-e053-2991aa0aee982023-02-20Name fallback
generic name: IODINE
IodiumIODINEBoiron85cd5e7a-52a7-0bb7-e053-2a91aa0aaa142023-01-23Name fallback
generic name: IODINE
IodiumIODINEBoiron85ccdc3f-5dd9-a5b1-e053-2a91aa0a8a0c2023-01-05Name fallback
generic name: IODINE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.